Cargando…

Development and validation of an interstitial lung disease exposure questionnaire for sub-Saharan Africa

BACKGROUND: American Thoracic Society/European Respiratory Society guidelines recommend context-specific exposure assessments to diagnose interstitial lung disease (ILD). In sub-Saharan Africa, ILD diagnoses are rare, and locally validated ILD exposure questionnaires are not used. METHODS: A physici...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, Peter, Padalkar, Roma, Katagira, Winceslaus, Mortimer, Kevin, Rykiel, Natalie A., Robertson, Nicole M., Pollard, Suzanne L., Alupo, Patricia, Checkley, William, Kirenga, Bruce, Siddharthan, Trishul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792102/
https://www.ncbi.nlm.nih.gov/pubmed/36578631
http://dx.doi.org/10.1183/23120541.00205-2022
_version_ 1784859561198354432
author Jackson, Peter
Padalkar, Roma
Katagira, Winceslaus
Mortimer, Kevin
Rykiel, Natalie A.
Robertson, Nicole M.
Pollard, Suzanne L.
Alupo, Patricia
Checkley, William
Kirenga, Bruce
Siddharthan, Trishul
author_facet Jackson, Peter
Padalkar, Roma
Katagira, Winceslaus
Mortimer, Kevin
Rykiel, Natalie A.
Robertson, Nicole M.
Pollard, Suzanne L.
Alupo, Patricia
Checkley, William
Kirenga, Bruce
Siddharthan, Trishul
author_sort Jackson, Peter
collection PubMed
description BACKGROUND: American Thoracic Society/European Respiratory Society guidelines recommend context-specific exposure assessments to diagnose interstitial lung disease (ILD). In sub-Saharan Africa, ILD diagnoses are rare, and locally validated ILD exposure questionnaires are not used. METHODS: A physician-administered ILD exposure questionnaire was developed using a four-step mixed-methods modified Delphi approach. First, ILD questionnaires from high-income countries and data from Pneumotox were reviewed, compiled and face-validated. Second, a local pilot group of ILD experts ranked item relevance using a Likert scale and suggested additions. Third, the questionnaire format and pilot rankings were addressed in a focus group discussion that was analysed using grounded theory. Finally, following focus group discussion modifications, the resulting items (with three duplicate item groups for evaluation of internal consistency) were ranked for importance by members of the Pan-African Thoracic Society (PATS). RESULTS: Face validation resulted in 82 items in four categories: “Smoking and Drugs”, “Environmental Exposures”, “Occupations” and “Medications”. Pilot group (n=10) ranking revealed 27 outliers and 30 novel suggestions. Focus group (n=12) discussion resulted in 10 item deletions, 14 additions and 22 re-wordings; themes included desire for extensive questionnaires and stigma sensitivity. Final validation involved 58 PATS members (mean±sd age 46±10.6  years, 76% male, from 17 countries) ranking 84 items derived from previous steps and three duplicate question groups. The questionnaire was internally consistent (Cronbach's α >0.80) and ultimately included 73 items. CONCLUSION: This mixed-methods study included experts from 17 countries in sub-Saharan Africa and successfully developed a 73-item ILD exposure questionnaire for sub-Saharan Africa. African pulmonary experts valued region-specific additions and ranked several items from existing ILD questionnaires as unimportant.
format Online
Article
Text
id pubmed-9792102
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-97921022022-12-27 Development and validation of an interstitial lung disease exposure questionnaire for sub-Saharan Africa Jackson, Peter Padalkar, Roma Katagira, Winceslaus Mortimer, Kevin Rykiel, Natalie A. Robertson, Nicole M. Pollard, Suzanne L. Alupo, Patricia Checkley, William Kirenga, Bruce Siddharthan, Trishul ERJ Open Res Original Research Articles BACKGROUND: American Thoracic Society/European Respiratory Society guidelines recommend context-specific exposure assessments to diagnose interstitial lung disease (ILD). In sub-Saharan Africa, ILD diagnoses are rare, and locally validated ILD exposure questionnaires are not used. METHODS: A physician-administered ILD exposure questionnaire was developed using a four-step mixed-methods modified Delphi approach. First, ILD questionnaires from high-income countries and data from Pneumotox were reviewed, compiled and face-validated. Second, a local pilot group of ILD experts ranked item relevance using a Likert scale and suggested additions. Third, the questionnaire format and pilot rankings were addressed in a focus group discussion that was analysed using grounded theory. Finally, following focus group discussion modifications, the resulting items (with three duplicate item groups for evaluation of internal consistency) were ranked for importance by members of the Pan-African Thoracic Society (PATS). RESULTS: Face validation resulted in 82 items in four categories: “Smoking and Drugs”, “Environmental Exposures”, “Occupations” and “Medications”. Pilot group (n=10) ranking revealed 27 outliers and 30 novel suggestions. Focus group (n=12) discussion resulted in 10 item deletions, 14 additions and 22 re-wordings; themes included desire for extensive questionnaires and stigma sensitivity. Final validation involved 58 PATS members (mean±sd age 46±10.6  years, 76% male, from 17 countries) ranking 84 items derived from previous steps and three duplicate question groups. The questionnaire was internally consistent (Cronbach's α >0.80) and ultimately included 73 items. CONCLUSION: This mixed-methods study included experts from 17 countries in sub-Saharan Africa and successfully developed a 73-item ILD exposure questionnaire for sub-Saharan Africa. African pulmonary experts valued region-specific additions and ranked several items from existing ILD questionnaires as unimportant. European Respiratory Society 2022-12-19 /pmc/articles/PMC9792102/ /pubmed/36578631 http://dx.doi.org/10.1183/23120541.00205-2022 Text en Copyright ©The authors 2022 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org)
spellingShingle Original Research Articles
Jackson, Peter
Padalkar, Roma
Katagira, Winceslaus
Mortimer, Kevin
Rykiel, Natalie A.
Robertson, Nicole M.
Pollard, Suzanne L.
Alupo, Patricia
Checkley, William
Kirenga, Bruce
Siddharthan, Trishul
Development and validation of an interstitial lung disease exposure questionnaire for sub-Saharan Africa
title Development and validation of an interstitial lung disease exposure questionnaire for sub-Saharan Africa
title_full Development and validation of an interstitial lung disease exposure questionnaire for sub-Saharan Africa
title_fullStr Development and validation of an interstitial lung disease exposure questionnaire for sub-Saharan Africa
title_full_unstemmed Development and validation of an interstitial lung disease exposure questionnaire for sub-Saharan Africa
title_short Development and validation of an interstitial lung disease exposure questionnaire for sub-Saharan Africa
title_sort development and validation of an interstitial lung disease exposure questionnaire for sub-saharan africa
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792102/
https://www.ncbi.nlm.nih.gov/pubmed/36578631
http://dx.doi.org/10.1183/23120541.00205-2022
work_keys_str_mv AT jacksonpeter developmentandvalidationofaninterstitiallungdiseaseexposurequestionnaireforsubsaharanafrica
AT padalkarroma developmentandvalidationofaninterstitiallungdiseaseexposurequestionnaireforsubsaharanafrica
AT katagirawinceslaus developmentandvalidationofaninterstitiallungdiseaseexposurequestionnaireforsubsaharanafrica
AT mortimerkevin developmentandvalidationofaninterstitiallungdiseaseexposurequestionnaireforsubsaharanafrica
AT rykielnataliea developmentandvalidationofaninterstitiallungdiseaseexposurequestionnaireforsubsaharanafrica
AT robertsonnicolem developmentandvalidationofaninterstitiallungdiseaseexposurequestionnaireforsubsaharanafrica
AT pollardsuzannel developmentandvalidationofaninterstitiallungdiseaseexposurequestionnaireforsubsaharanafrica
AT alupopatricia developmentandvalidationofaninterstitiallungdiseaseexposurequestionnaireforsubsaharanafrica
AT checkleywilliam developmentandvalidationofaninterstitiallungdiseaseexposurequestionnaireforsubsaharanafrica
AT kirengabruce developmentandvalidationofaninterstitiallungdiseaseexposurequestionnaireforsubsaharanafrica
AT siddharthantrishul developmentandvalidationofaninterstitiallungdiseaseexposurequestionnaireforsubsaharanafrica